Stay updated on Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial page.

Latest updates to the Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.5.2 added and Revision: v3.5.0 removed. This appears to be a version label update with no changes to study details.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check42 days agoChange DetectedA new revision v3.5.0 has been added. The previous revision v3.4.3 has been removed.SummaryDifference0.1%

- Check49 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check71 days agoChange DetectedGastric cancer is added as a related topic and the Genetic and Rare Diseases Information Center is now listed under Resources. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check78 days agoChange DetectedAdded Revision: v3.4.2. Removed the notice about lapse in government funding and the older Revision: v3.4.1 banner.SummaryDifference0.5%

- Check85 days agoChange DetectedAdded a government funding status notice banner and updated the site revision from v3.4.0 to v3.4.1. The study details and related information remain unchanged.SummaryDifference0.5%

Stay in the know with updates to Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial page.